Wed, May 10, 2023

Edward Nash Maintained (VRNA) at Sell with Increased Target to $33 on, May 10th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-33-on-may-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Edward Nash of Canaccord Genuity, Maintained "Verona Pharma plc" (VRNA) at Sell with Increased Target from $31 to $33 on, May 10th, 2023.

Edward has made no other calls on VRNA in the last 4 months.



There is 1 other peer that has a rating on VRNA. Out of the 1 peers that are also analyzing VRNA, 0 agree with Edward's Rating of Hold.



This is the rating of the analyst that currently disagrees with Edward


  • Thomas Shrader of "BTIG" Maintained at Strong Buy with Increased Target to $31 on, Monday, March 20th, 2023

Publication Contributing Sources